Pflipsen M, Massaquoi M, Wolf S (2016) Evaluation of the painful eye. Am Fam Physician 93(12):991–998

PubMed  Google Scholar 

Galor A, Levitt RC, Felix ER, Martin ER, Sarantopoulos CD (2015) Neuropathic ocular pain: an important yet underevaluated feature of dry eye. Eye 29(3):301–312. https://doi.org/10.1038/eye.2014.263

Article  CAS  PubMed  Google Scholar 

Borsook D, Kussman BD, George E, Becerra LR, Burke DW (2013) Surgically induced neuropathic pain: understanding the perioperative process. Ann Surg 257(3):403–412. https://doi.org/10.1097/SLA.0b013e3182701a7b

Article  PubMed  Google Scholar 

Ellis A, Bennett DLH (2013) Neuroinflammation and the generation of neuropathic pain. Br J Anaesth 111(1):26–37. https://doi.org/10.1093/bja/aet128

Article  CAS  PubMed  Google Scholar 

Mitsikostas DD, Moka E, Orrillo E et al (2022) Neuropathic pain in neurologic disorders: a narrative review. Cureus 14(2):e22419. https://doi.org/10.7759/cureus.22419

Article  PubMed  PubMed Central  Google Scholar 

Jacobs DS (2017) Diagnosis and treatment of ocular pain: the ophthalmologist’s perspective. Curr Ophthalmol Rep 5(4):271–275. https://doi.org/10.1007/s40135-017-0152-1

Article  PubMed  PubMed Central  Google Scholar 

Chincholkar M (2020) Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice. Br J Pain 14(2):104–114. https://doi.org/10.1177/2049463720912496

Article  PubMed  PubMed Central  Google Scholar 

Peckham AM, Evoy KE, Ochs L, Covvey JR (2018) Gabapentin for off-label use: evidence-based or cause for concern? Subst Abuse 12:1178221818801311. https://doi.org/10.1177/1178221818801311

Article  PubMed  PubMed Central  Google Scholar 

Hamer AM, Haxby DG, McFarland BH, Ketchum K (2002) Gabapentin use in a managed medicaid population. J Manag Care Pharm 8(4):266–271. https://doi.org/10.18553/jmcp.2002.8.4.266

Article  PubMed  Google Scholar 

Fukada C, Kohler JC, Boon H, Austin Z, Krahn M (2012) Prescribing gabapentin off label: perspectives from psychiatry, pain and neurology specialists. Can Pharm J (Ott) 145(6):280-284.e1. https://doi.org/10.3821/145.6.cpj280

Article  PubMed  Google Scholar 

Goodman CW, Brett AS (2019) Gabapentinoids for pain: potential unintended consequences. Am Fam Physician 100(11):672–675

PubMed  Google Scholar 

Rullán M, Bulilete O, Leiva A et al (2017) Efficacy of gabapentin for prevention of postherpetic neuralgia: study protocol for a randomized controlled clinical trial. Trials 18(1):24. https://doi.org/10.1186/s13063-016-1729-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bulilete O, Leiva A, Rullán M, Roca A, Llobera J (2019) Efficacy of gabapentin for the prevention of postherpetic neuralgia in patients with acute herpes zoster: a double blind, randomized controlled trial. PLoS ONE 14(6):e0217335. https://doi.org/10.1371/journal.pone.0217335

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamauchi T, Kaneko S, Yagi K, Sase S (2006) Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study. Psychiatry Clin Neurosci 60(4):507–515. https://doi.org/10.1111/j.1440-1819.2006.01553.x

Article  CAS  PubMed  Google Scholar 

Kume A (2014) Gabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1200 mg dose? Neuropsychiatr Dis Treat 10:249–262. https://doi.org/10.2147/ndt.S30160

Article  PubMed  PubMed Central  Google Scholar 

Kneib CJ, Sibbett SH, Carrougher GJ, Muffley LA, Gibran NS, Mandell SP (2019) The effects of early neuropathic pain control with gabapentin on long-term chronic pain and itch in burn patients. J Burn Care Res 40(4):457–463. https://doi.org/10.1093/jbcr/irz036

Article  PubMed  Google Scholar 

Ben-Menachem E (2004) Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 45(Suppl 6):13–18. https://doi.org/10.1111/j.0013-9580.2004.455003.x

Article  CAS  PubMed  Google Scholar 

Alles SRA, Cain SM, Snutch TP (2020) Pregabalin as a pain therapeutic: beyond calcium channels. Front Cell Neurosci 14:83. https://doi.org/10.3389/fncel.2020.00083

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goa KL, Gabapentin SEM (1993) A review of its pharmacological properties and clinical potential in epilepsy. Drugs 46(3):409–427. https://doi.org/10.2165/00003495-199346030-00007

Article  CAS  PubMed  Google Scholar 

Alghamdi K, Lysecki D (2023) Role of gabapentin in reducing the need for high-risk medications in patients with stable severe neurological impairment. J Taibah Univ Med Sci 18(1):170–174. https://doi.org/10.1016/j.jtumed.2022.07.006

Article  PubMed  Google Scholar 

Patel R, Dickenson AH (2016) Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain. Pharmacol Res Perspect 4(2):e00205. https://doi.org/10.1002/prp2.205

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Z, Taylor CP, Weber M et al (2011) Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits. Eur J Pharmacol 667(1–3):80–90. https://doi.org/10.1016/j.ejphar.2011.05.054

Article  CAS  PubMed  Google Scholar 

Takahashi DK, Jin S, Prince DA (2018) Gabapentin prevents progressive increases in excitatory connectivity and epileptogenesis following neocortical trauma. Cereb Cortex 28(8):2725–2740. https://doi.org/10.1093/cercor/bhx152

Article  CAS  PubMed  Google Scholar 

Rossi A, Murta V, Auzmendi J, Ramos AJ (2017) Early gabapentin treatment during the latency period increases convulsive threshold, reduces microglial activation and macrophage infiltration in the lithium-pilocarpine model of epilepsy. Pharmaceuticals (Basel) 10(4):93. https://doi.org/10.3390/ph10040093

Article  CAS  PubMed  Google Scholar 

Foldvary-Schaefer N, De Leon SI, Karafa M, Mascha E, Dinner D, Morris HH (2002) Gabapentin increases slow-wave sleep in normal adults. Epilepsia 43(12):1493–1497. https://doi.org/10.1046/j.1528-1157.2002.21002.x

Article  CAS  PubMed  Google Scholar 

Wilson SE (2020) Biology of keratorefractive surgery- PRK, PTK, LASIK, SMILE, inlays and other refractive procedures. Exp Eye Res 198:108136. https://doi.org/10.1016/j.exer.2020.108136

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alio JL, Javaloy J (2013) Corneal inflammation following corneal photoablative refractive surgery with excimer laser. Surv Ophthalmol 58(1):11–25. https://doi.org/10.1016/j.survophthal.2012.04.005

Article  PubMed  Google Scholar 

Spadea L, Giovannetti F (2019) Main complications of photorefractive keratectomy and their management. Clin Ophthalmol 13:2305–2315. https://doi.org/10.2147/opth.S233125

Article  PubMed  PubMed Central  Google Scholar 

Kahuam-López N, Navas A, Castillo-Salgado C, Graue-Hernandez EO, Jimenez-Corona A, Ibarra A (2020) Laser-assisted in-situ keratomileusis (LASIK) with a mechanical microkeratome compared to LASIK with a femtosecond laser for LASIK in adults with myopia or myopic astigmatism. Cochrane Database Syst Rev 4(4):Cd012946. https://doi.org/10.1002/14651858.CD012946.pub2

Article  PubMed